Deutsche Märkte geschlossen

Baxter International Inc. (BAX)

NYSE - NYSE Verzögerter Preis. Währung in USD
Zur Watchlist hinzufügen
81,09-0,36 (-0,44%)
Börsenschluss: 4:00PM EDT

Baxter International Inc.

One Baxter Parkway
Deerfield, IL 60015
United States
224 948 2000

BrancheMedical Instruments & Supplies

Leitende Angestellte

Mr. José E. AlmeidaChairman, Pres & CEO2,12MN/A1962
Mr. James K. SaccaroExec. VP & CFO835,03kN/A1973
Mr. Sean B. W. MartinSr. VP & Gen. Counsel1,33MN/A1963
Mr. Giuseppe AccogliSr. VP & Pres of Americas and Global Bus. Units1,52M1,4M1971
Mr. Cristiano FranziSr. VP & Pres for EMEA1,5MN/A1963
Mr. Brian C. StevensSr. VP, Chief Accounting Officer & ControllerN/AN/A1975
Dr. Sumant RamachandraPres of Pharmaceuticals and Sr. VP, Chief Science & Technology OfficerN/AN/A1969
Mr. Talvis P. LoveSr. VP & Chief Information OfficerN/AN/AN/A
Ms. Clare TrachtmanVP of Investor RelationsN/AN/AN/A
Ms. Jeanne K. MasonSr. VP of HRN/AN/A1956
Die Beträge haben den Stand 31. Dezember 2019 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.


Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. It also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.

Corporate Governance

Baxter International Inc.s ISS Governance QualityScore, Stand 6. Oktober 2020, lautet 9. Die grundlegenden Scores sind Audit: 10, Vorstand: 9, Shareholderrechte: 5, Kompensation: 6.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.